Ocular Therapeutix, Inc.OCULNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-1.56%
↑ 74% above average
Average (39q)
-5.95%
Historical baseline
Range
High:22.37%
Low:-57.69%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -1.56% |
| Q2 2025 | -5.83% |
| Q1 2025 | -26.38% |
| Q4 2024 | -9.95% |
| Q3 2024 | -5.52% |
| Q2 2024 | -37.87% |
| Q1 2024 | -57.69% |
| Q4 2023 | -4.35% |
| Q3 2023 | 6.59% |
| Q2 2023 | 8.78% |
| Q1 2023 | -16.47% |
| Q4 2022 | 10.13% |
| Q3 2022 | -8.17% |
| Q2 2022 | -11.68% |
| Q1 2022 | 1.20% |
| Q4 2021 | 7.58% |
| Q3 2021 | 3.47% |
| Q2 2021 | -0.01% |
| Q1 2021 | -41.03% |
| Q4 2020 | -2.41% |
| Q3 2020 | 21.68% |
| Q2 2020 | -7.64% |
| Q1 2020 | 22.37% |
| Q4 2019 | 7.53% |
| Q3 2019 | -7.15% |
| Q2 2019 | -9.87% |
| Q1 2019 | -13.74% |
| Q4 2018 | -16.65% |
| Q3 2018 | -9.23% |
| Q2 2018 | -0.81% |
| Q1 2018 | -5.81% |
| Q4 2017 | 16.32% |
| Q3 2017 | 17.14% |
| Q2 2017 | -17.02% |
| Q1 2017 | -25.66% |
| Q4 2016 | -35.01% |
| Q3 2016 | 16.83% |
| Q2 2016 | -5.69% |
| Q1 2016 | -2.28% |
| Q4 2015 | 8.05% |